Thus, regulating peripheric AMPK-SIRT1 pathway was probably one of the mechanisms of HLJDD in the treatment of AD rats, which involved the alleviation of oxidative stress, inflammation, and energy metabolism. The gene discussed is SIRT1; the disease is Alzheimer disease.